Exploring Stakeholder Perceptions about Using Artificial Intelligence for the Diagnosis of Rare and Atypical Infections
Applied Clinical Informatics · 01.01.2025 · 16 (01) · 223-233
DOI: 10.1055/a-2451-9046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Clinical Informatics, erschienen am 01.01.2025. Verfasst von Aysun Tekin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, United States. Hauptthemen laut MEDLINE: Artificial Intelligence, Infections, Stakeholder Participation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: AHRQ HHS, NCATS NIH HHS, Minnesota Partnership for Biotechnology and Medical Genomics.
Abstract (Originalsprache)
Objectives
This study aimed to evaluate critical care provider perspectives about diagnostic practices for rare and atypical infections and the potential for using artificial intelligence (AI) as a decision support system (DSS).
Methods
We conducted an anonymous web-based survey among critical care providers at Mayo Clinic Rochester between November 25, 2023, and January 15, 2024, to evaluate their experience with rare and atypical infection diagnostic processes and AI-based DSSs. We also assessed the perceived usefulness of AI-based DSSs, their potential impact on improving diagnostic practices for rare and atypical infections, and the perceived risks and benefits of their use.
Results
A total of 47/143 providers completed the survey. Thirty-eight out of 47 agreed that there was a delay in diagnosing rare and atypical infections. Among those who agreed, limited assessment of specific patient factors and failure to consider them were the most frequently cited important contributing factors (33/38). Thirty-eight out of 47 reported familiarity with the AI-based DSS applications available to critical care providers. Less than half (18/38) thought AI-based DSSs often provided valuable insights into patient care, but almost three-quarters (34/47) thought AI-based DDSs often provided valuable insight when specifically asked about their ability to improve the diagnosis of rare and atypical infections. All respondents rated reliability as important in enhancing the perceived utility of AI-based DSSs (47/47) and almost all rated interpretability and integration into the workflow as important (45/47). The primary concern about implementing an AI-based DSS in this context was alert fatigue (44/47).
Conclusion
Most critical care providers perceive that there are delays in diagnosing rare infections, indicating inadequate assessment and consideration of the diagnosis as the major contributors. Reliability, interpretability, workflow integration, and alert fatigue emerged as key factors impacting the usability of AI-based DSS. These findings will inform the development and implementation of an AI-based diagnostic algorithm to aid in identifying rare and atypical infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, United States.
- Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, United States.
- Department of Physical Medicine and Rehabilitation Research, Mayo Clinic, Rochester, Minnesota, United States.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, United States.
Förderung
- AHRQ HHS
- NCATS NIH HHS
- Minnesota Partnership for Biotechnology and Medical Genomics
- Benefactor funding via Mayo Clinic Rochester Division of Pulmonary and Critical Care Medicine
- National Center for Advancing Translational Sciences
Zitieren
APA
Tekin, A., Herasevich, S., Minteer, S. A., Gajic, O., & Barwise, A. K. (2025). Exploring Stakeholder Perceptions about Using Artificial Intelligence for the Diagnosis of Rare and Atypical Infections. Applied Clinical Informatics, 16(01), 223-233. https://doi.org/10.1055/a-2451-9046
Vancouver
Tekin A, Herasevich S, Minteer SA, Gajic O, Barwise AK. Exploring Stakeholder Perceptions about Using Artificial Intelligence for the Diagnosis of Rare and Atypical Infections. Applied Clinical Informatics. 2025;16(01):223-233. doi:10.1055/a-2451-9046
BibTeX
@article{Tekin2025,
author = {Tekin, Aysun and Herasevich, Svetlana and Minteer, Sarah A and Gajic, Ognjen and Barwise, Amelia K},
title = {Exploring Stakeholder Perceptions about Using Artificial Intelligence for the Diagnosis of Rare and Atypical Infections},
journal = {Applied Clinical Informatics},
year = {2025},
volume = {16},
number = {01},
pages = {223--233},
doi = {10.1055/a-2451-9046}
}
EUVIMED